|
ATCC
a375m human melanoma cell line A375m Human Melanoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a375m/A375%3B+Melanoma%3B+Human/pmc12828906-90-0-9 Average 97 stars, based on 1 article reviews
a375m human melanoma cell line - by Bioz Stars,
2026-09
97/100 stars
|
Buy from Supplier |
|
Korean Cell Line Bank
a375m cells A375m Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a375m/cancer+cell+colon+line+sw620/pm41935307-42-4-10 Average 86 stars, based on 1 article reviews
a375m cells - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
dabrafenib resistant a375m Dabrafenib Resistant A375m, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a375m/Dabrafenib/pmc10787166__mmc2-200-3-30 Average 96 stars, based on 1 article reviews
dabrafenib resistant a375m - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
vemurafenib resistant a375m Vemurafenib Resistant A375m, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a375m/Vemurafenib/pmc10787166__mmc2-200-0-30 Average 96 stars, based on 1 article reviews
vemurafenib resistant a375m - by Bioz Stars,
2026-09
96/100 stars
|
Buy from Supplier |
|
Charles River Laboratories
a375m-dr-lucgfp cells A375m Dr Lucgfp Cells, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a375m/a375+cells/pm37990493-293-1-36 Average 90 stars, based on 1 article reviews
a375m-dr-lucgfp cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
ATCC
crl 2558 a375m Crl 2558 A375m, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a375m/PL45/pmc11528448__ijbsv20p5495s1-39-5-3 Average 95 stars, based on 1 article reviews
crl 2558 a375m - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
ATCC
human melanoma cell line a375m ![]() Human Melanoma Cell Line A375m, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/a375m/A-375/pmc10707163-162-18-23 Average 99 stars, based on 1 article reviews
human melanoma cell line a375m - by Bioz Stars,
2026-09
99/100 stars
|
Buy from Supplier |
Journal: International Journal of Molecular Sciences
Article Title: Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveolin-1-Enhanced Migration, Invasion, and Metastasis in Melanoma Models
doi: 10.3390/ijms242316947
Figure Lengend Snippet: PGE2 increases migration and invasion of A375M (CAV1/E-cad) cells. A375 (Mock) and A375 (CAV1) cell lines cultured in the presence of IPTG were transiently transfected with pBATEM for 48 h to express E-cad. A375 (Mock), A375 (CAV1), A375 (E-cad), and A375 (CAV1/E-cad) cells were treated with 50 μM of PGE2 for 5 h. Then, the extracts were either prepared for immunoprecipitation experiments or cell migration and invasion measurements in transwell and matrigel assays, respectively. ( A ) CAV1 was immunoprecipitated from protein extracts using a polyclonal antibody. Immunoprecipitated CAV1 and co-immunoprecipitated E-cad were detected via Western blotting. ( B ) Representative Western blot of immunoprecipitates obtained in three independent experiments. E-cad and CAV1 protein levels were quantified in several experiments via densitometry and normalized to actin (mean ± SD, n = 3; ** p < 0.01). A375 (Mock), A375 (CAV1), A375 (E-cad), and A375 (E-cad/CAV1) cells were serum-deprived for 5 h and treated with PGE2 (50 μM) for 2 h. Then, CAV1 was immunoprecipitated from the protein extracts using a polyclonal antibody. Immunoprecipitated CAV1 and co-immunoprecipitated E-cad were detected via Western blotting. ( B ) Graph showing the CAV1 as normalized pixels (mean ± SEM) for each condition; n = 3; and ** p < 0.01 with respect to A375 (mock). ( C ) Graph showing E-cad as normalized pixels (mean ± SEM) for each condition; n = 3; ** p < 0.01 with respect to A375 (mock). ( D ) CAV1/E-cad as normalized pixels (mean ± SEM) for each condition; n = 3; and * p < 0.05 or ** p < 0.01 with respect to A375 (mock). ( E ) A375 (Mock), A375 (CAV1), A375 (E-cad), and A375 (E-cad/CAV1) cells were treated with 50 μM of PGE2 for 5 h. Then, 150.000 cells were seeded into Boyden chambers (transwells) in the presence of 50 μM PGE2. Migration was measured after 2 h. Significant differences are shown (* p < 0.05; n = 3). ( F ) Panels showing representative images of results obtained for cells migrating either without treatment (basal condition, upper panel ) or when treated with 50 μM of PGE2 for 5 h ( lower panel ), in both cases stained with crystal violet. ( H ) Cells cultured in the presence or absence of 50 µM of PGE2 for 5 h were used for the invasion assays. Cells (150.000) were seeded into matrigel Boyden chambers in the presence of 50 μM of PGE2. Invasion was measured after 48 h. Graphs show averages (mean ± SEM; n = 3). Significant differences are indicated (* p < 0.05). ( G ) Panel showing representative images obtained in invasion assays for cells cultured in the absence (basal condition, upper panel ) or presence ( lower panel ) of 50 μM of PGE2, in both cases stained with DAPI Bar = 50 μm. (* p < 0.05; ** p < 0.01; *** p < 0.001; n = 3).
Article Snippet: B16F10 metastatic murine melanoma cells (ATCC, #CRL6475, provided by Laurence Zitvogel, Institut Gustav Roussy, Villejuif, France) and the
Techniques: Migration, Cell Culture, Transfection, Immunoprecipitation, Western Blot, Staining